ZL-1218
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZL-1218, covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors [Phase 1]